Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy-Reference-Cited by-同舟云学术

Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy

Published:2017-03-16 Issue:5 Volume:65 Page:1765-1768
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Ren Yan-Dan¹,Ye Zhen-Shi¹,Yang Liu-Zhu¹,Jin Li-Xin¹,Wei Wen-Jun¹,Deng Yong-Yue²,Chen Xiao-Xiao²,Xiao Chuan-Xing¹,Yu Xiao-Fang³,Xu Hong-Zhi¹,Xu Li-Zhu¹,Tang Yun-Na¹,Zhou Fei¹,Wang Xue-Lian²,Chen Mei-Ya¹,Chen Li-Gang¹,Hong Mei-Zhu⁴,Ren Jian-Lin¹,Pan Jin-Shui¹

Affiliation:

1. Zhongshan Hospital Department of Gastroenterology, Xiamen University; Xiamen China

2. Zhongshan Hospital Department of Infectious Diseases; Xiamen University; Xiamen China

3. Hepatology Unit and Department of Infectious Diseases; Xiamen Hospital of Traditional Chinese Medicine; Xiamen China

4. Zhongshan Hospital Department of Traditional Chinese Medicine; Xiamen University; Xiamen China

Funder

National Science Foundation for Young Scholars, China

Key Foundation of Health System for Young Talents of Fujian

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.29008/fullpdf

Reference5 articles.

1. AASLD guidelines for treatment of chronic hepatitis B;Terrault;Hepatology,2016

3. Characterization of fecal microbial communities in patients with liver cirrhosis;Chen;Hepatology,2011

4. Alterations of the human gut microbiome in liver cirrhosis;Qin;Nature,2014

5. Functional interactions between the gut microbiota and host metabolism;Tremaroli;Nature,2012

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of intestinal microbiota transplantation on chronic hepatitis B virus infection associated liver disease;Frontiers in Microbiology;2024-09-11

2. Faecal microbiota transplantation associated adverse events;Current Issues in Pharmacy and Medical Sciences;2024-09-01

3. Alterations in the gut microbiome after transjugular intrahepatic portosystemic shunt in patients with hepatitis B virus-related portal hypertension;World Journal of Gastroenterology;2024-08-21

4. Therapeutic manipulation of the microbiome in liver disease;Hepatology;2024-06-26

5. A Predictive Model Based on the FBXO Family Reveals the Significance of Cyclin F in Hepatocellular Carcinoma;Frontiers in Bioscience-Landmark;2024-05-24